Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL SACRAL NERVE STIMULATION (SNS) MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL SACRAL NERVE STIMULATION (SNS) MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL SACRAL NERVE STIMULATION (SNS) MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 INDUSTRY INSIGHTS
7 REGULATORY FRAMWORK
8 IMPACT OF COVID-19 PANDEMIC ON THE MARKET
8.1 PRICE IMPACT
8.2 IMPACT ON DEMAND
8.3 IMPACT ON SUPPLY CHAIN
8.4 STRATEGIC DECISION FOR MANUFACTURERS/SERVICE PROVIDERS
8.5 CONCLUSION
9 GLOBAL SACRAL NERVE STIMULATION (SNS) MARKET, BY PRODUCT
9.1 OVERVIEW
9.2 IMPLANTABLE SNS DEVICES
9.3 EXTERNAL SNS DEVICES
10 GLOBAL SACRAL NERVE STIMULATION (SNS) MARKET, BY TYPE
10.1 OVERVIEW
10.2 ELECTRICAL MUSCLE STIMULATION
10.3 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION
11 GLOBAL SACRAL NERVE STIMULATION (SNS) MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 URINARY INCONTINENCE
11.3 FECAL INCONTINENCE
11.4 URGE INCONTINENCE
11.5 CHRONIC ANAL FISSURE
11.6 BLADDER OVER ACTIVITY
11.7 OTHERS
12 GLOBAL SACRAL NERVE STIMULATION (SNS) MARKET, BY AGE GROUP
12.1 OVERVIEW
12.2 ADULTS
12.3 GERIATRIC
12.4 CHILDREN
13 GLOBAL SACRAL NERVE STIMULATION (SNS) MARKET, BY END USER
13.1 OVERVIEW
13.2 HOSPITALS
13.2.1 ACUTE CARE HOSPITALS
13.2.2 LONG-TERM CARE HOSPITALS
13.2.3 NURSING FACILITIES
13.2.4 REHABILITATION CENTERS
13.3 SPECIALTY CLINICS
13.4 RESEARCH CENTERS
13.5 OTHERS
14 GLOBAL SACRAL NERVE STIMULATION (SNS) MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 DIRECT TENDER
14.3 THIRD PARTY DISTRIBUTORS
14.4 OTHERS
15 GLOBAL SACRAL NERVE STIMULATION (SNS) MARKET, BY COUNTRY
GLOBAL SACRAL NERVE STIMULATION (SNS) MARKET (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
15.1.1 NORTH AMERICA
15.1.1.1. U.S.
15.1.1.2. CANADA
15.1.1.3. MEXICO
15.1.2 EUROPE
15.1.2.1. GERMANY
15.1.2.2. FRANCE
15.1.2.3. U.K.
15.1.2.4. ITALY
15.1.2.5. SPAIN
15.1.2.6. RUSSIA
15.1.2.7. TURKEY
15.1.2.8. BELGIUM
15.1.2.9. NETHERLANDS
15.1.2.10. SWITZERLAND
15.1.2.11. REST OF EUROPE
15.1.3 ASIA-PACIFIC
15.1.3.1. JAPAN
15.1.3.2. CHINA
15.1.3.3. SOUTH KOREA
15.1.3.4. INDIA
15.1.3.5. AUSTRALIA
15.1.3.6. SINGAPORE
15.1.3.7. THAILAND
15.1.3.8. MALAYSIA
15.1.3.9. INDONESIA
15.1.3.10. PHILIPPINES
15.1.3.11. REST OF ASIA-PACIFIC
15.1.4 SOUTH AMERICA
15.1.4.1. BRAZIL
15.1.4.2. ARGENTINA
15.1.4.3. REST OF SOUTH AMERICA
15.1.5 MIDDLE EAST AND AFRICA
15.1.5.1. SOUTH AFRICA
15.1.5.2. SAUDI ARABIA
15.1.5.3. UAE
15.1.5.4. EGYPT
15.1.5.5. ISRAEL
15.1.5.6. REST OF MIDDLE EAST AND AFRICA
15.1.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
16 GLOBAL SACRAL NERVE STIMULATION (SNS) MARKET, COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: GLOBAL
16.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
16.3 COMPANY SHARE ANALYSIS: EUROPE
16.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
16.5 MERGERS & ACQUISITIONS
16.6 NEW PRODUCT DEVELOPMENT & APPROVALS
16.7 EXPANSIONS
16.8 REGULATORY CHANGES
16.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
17 GLOBAL SACRAL NERVE STIMULATION (SNS) MARKET, SWOT AND DBMR ANALYSIS
18 GLOBAL SACRAL NERVE STIMULATION (SNS) MARKET, COMPANY PROFILE
18.1 MEDTRONIC
18.1.1 COMPANY OVERVIEW
18.1.2 REVENUE ANALYSIS
18.1.3 GEOGRAPHIC PRESENCE
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENTS
18.2 LABORIE, INC.
18.2.1 COMPANY OVERVIEW
18.2.2 REVENUE ANALYSIS
18.2.3 GEOGRAPHIC PRESENCE
18.2.4 PRODUCT PORTFOLIO
18.2.5 RECENT DEVELOPMENTS
18.3 SUNMED
18.3.1 COMPANY OVERVIEW
18.3.2 REVENUE ANALYSIS
18.3.3 GEOGRAPHIC PRESENCE
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPEMENTS
18.4 VYGON SAS
18.4.1 COMPANY OVERVIEW
18.4.2 REVENUE ANALYSIS
18.4.3 GEOGRAPHIC PRESENCE
18.4.4 PRODUCT PORTFOLIO
18.4.5 RECENT DEVELOPEMENTS
18.5 AXONICS MODULATION TECHNOLOGIES, INC.
18.5.1 COMPANY OVERVIEW
18.5.2 REVENUE ANALYSIS
18.5.3 GEOGRAPHIC PRESENCE
18.5.4 PRODUCT PORTFOLIO
18.5.5 RECENT DEVELOPEMENTS
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST RELATED REPORTS
19 CONCLUSION
20 QUESTIONNAIRE
21 ABOUT DATA BRIDGE MARKET RESEARCH
